의료진프로필

Role of invasive mediastinal nodal staging in survival outcomes of patients with non-small cell lung cancer and without radiologic lymph node metastasis: a retrospective cohort study

Kim, HK; Jeon, YJ; Um, SW; Shin, SH; Jeong, BH; Lee, K; Kim, H; Lee, HY; Kim, TJ; Lee, KS; Choi, YL; Han, JH; Ahn, YC; Pyo, H; Noh, JM; Choi, JY; Cho, JH; Choi, YS; Zo, JI; Shim, YM; Hwang, SS; Kim, J

Hypofractionated radiation therapy combined with androgen deprivation therapy for high-risk localized prostate cancer

Lee, TH; Pyo, H; Yoo, GS; Jeon, SS; Seo, SI; Jeong, BC; Jeon, HG; Sung, HH; Kang, MY; Song, W; Chung, JH; Bae, BK; Park, W

Prospective study investigating hypofractionated proton beam therapy in patients with inoperable early stage non-small cell lung cancer

Yang, K; Noh, JM; Park, HY; Yoo, H; Shin, SH; Pyo, H

Long-term findings of rectal endoscopy and rectal bleeding after moderately hypofractionated, intensity-modulated radiotherapy for prostate cancer

Bae, BK; Kim, JE; Pyo, H; Hong, SN; Park, W

Quantification of diffuse parenchymal lung disease in non-small cell lung cancer patients with definitive concurrent chemoradiation therapy for predicting radiation pneumonitis

An, YC; Kim, JH; Noh, JM; Yang, KM; Oh, YJ; Park, SG; Pyo, HR; Lee, HY

Prognostic Significance of Volumetric Parameters Based on FDG PET/CT in Patients with Lung Adenocarcinoma Undergoing Curative Surgery

Lee, H; Choi, YL; Kim, HK; Choi, YS; Kim, H; Ahn, MJ; Pyo, HR; Choi, JY

Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer

Lee, TH; Pyo, H; Yoo, GS; Lee, HM; Jeon, SS; Il Seo, S; Jeong, BC; Jeon, HG; Sung, HH; Kang, M; Song, W; Chung, JH; Bae, BK; Park, W

The Incidence and Risk Factors of Chronic Pulmonary Infection after Radiotherapy in Patients with Lung Cancer

Choi, Y; Noh, JM; Shin, SH; Lee, KYJ; Um, SW; Kim, H; Pyo, H; Ahn, YC; Jeong, BH

Radiomics Analysis of F-18-FDG PET/CT for Prognosis Prediction in Patients with Stage III Non-Small Cell Lung Cancer Undergoing Neoadjuvant Chemoradiation Therapy Followed by Surgery

Yoo, J; Lee, JH; Cheon, M; Kim, H; Choi, YS; Pyo, H; Ahn, MJ; Choi, JY

Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder

Kim, H; Jeong, BC; Hong, J; Kwon, GY; Kim, CK; Park, W; Pyo, H; Song, W; Sung, HH; Hong, JY; Park, SH

Whole-Section Landscape Analysis of Molecular Subtypes in Curatively Resected Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Significance

Hwang, S; Hong, TH; Kim, HK; Choi, YS; Zo, JI; Shim, YM; Han, J; Ahn, YC; Pyo, H; Noh, JM; Lee, HY; Kim, HJ; Park, S; Ahn, MJ; Park, K; Lee, SH; Choi, YL; Kim, J

Reduced radiation exposure to circulating blood cells in proton therapy compared with X-ray therapy in locally advanced lung cancer: Computational simulation based on circulating blood cells

Kim, N; Shin, J; Ahn, SH; Pyo, H; Noh, JM; Yang, K; Lee, W; Park, B

Association of T Cell Senescence with Radiation Pneumonitis in Patients with Non-small Cell Lung Cancer

Kim, KH; Pyo, H; Lee, H; Oh, D; Noh, JM; Ahn, YC; Kim, CG; Yoon, HI; Lee, J; Park, S; Jung, HA; Sun, JM; Lee, SH; Ahn, JS; Park, K; Ku, BM; Shin, EC; Ahn, MJ

Clinical Outcomes Following Proton and Photon Stereotactic Body Radiation Therapy for Early-Stage Lung Cancer

Bae, BK; Yang, K; Noh, JM; Pyo, H; Ahn, YC

Proton Beam Therapy versus Photon Radiotherapy for Stage I Non-Small Cell Lung Cancer

Suh, YG; Noh, JM; Lee, DY; Kim, TH; Bayasgalan, U; Pyo, H; Moon, SH

Prognostic Significance of Pseudotime from Texture Parameters of FDG PET/CT in Locally Advanced Non-Small-Cell Lung Cancer with Tri-Modality Therapy

Lee, H; Kim, H; Choi, YS; Pyo, HR; Ahn, MJ; Choi, JY

Dynamics of Circulating Immune Cells During Chemoradiotherapy in Patients with Non-Small Cell Lung Cancer Support Earlier Administration of Anti-PD-1/PD-L1

Kim, KH; Pyo, H; Lee, H; Oh, D; Noh, JM; Ahn, YC; Yoon, HI; Moon, H; Lee, J; Park, S; Jung, HA; Sun, JM; Lee, SH; Ahn, JS; Park, K; Ku, BM; Ahn, MJ; Shin, EC

Predictive Value of F-18-FDG PET/CT Using Machine Learning for Pathological Response to Neoadjuvant Concurrent Chemoradiotherapy in Patients with Stage III Non-Small Cell Lung Cancer

Yoo, J; Lee, J; Cheon, M; Woo, SK; Ahn, MJ; Pyo, HR; Choi, YS; Han, JH; Choi, JY

Prospective Study of Proton Therapy for Lung Cancer Patients with Poor Lung Function or Pulmonary Fibrosis

Noh, JM; Yoo, H; Lee, W; Park, HY; Shin, SH; Pyo, H

Toxicity of Proton Therapy versus Photon Therapy on Salvage Re-Irradiation for Non-Small Cell Lung Cancer

Yang, K; Suh, YG; Shin, H; Pyo, H; Moon, SH; Ahn, YC; Oh, D; Chung, E; Jo, K; Noh, JM

Targeted Liquid Biopsy Using Irradiation to Facilitate the Release of Cell-Free DNA from a Spatially Aimed Tumor Tissue

Noh, JM; Kim, YJ; Lee, HY; Choi, C; Ahn, WG; Lee, T; Pyo, H; Park, JH; Park, D; Park, WY

Feasibility of Synthetic Computed Tomography Images Generated from Magnetic Resonance Imaging Scans Using Various Deep Learning Methods in the Planning of Radiation Therapy for Prostate Cancer

Yoo, GS; Luu, HM; Kim, H; Park, W; Pyo, H; Han, Y; Park, JY; Park, SH

Risk Factors and Patterns of Locoregional Recurrence after Radical Nephrectomy for Locally Advanced Renal Cell Carcinoma

Yoo, GS; Park, W; Pyo, H; Jeong, BC; Jeon, HG; Kang, M; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Park, BK; Kim, CK; Park, SY; Kwon, GY

Clinical Outcomes of Pencil Beam Scanning Proton Therapy in Locally Advanced Non-Small Cell Lung Cancer: Propensity Score Analysis

Kim, N; Noh, JM; Lee, W; Park, B; Pyo, H

Clinical and dosimetric risk factors for vertebral compression fracture after single-fraction stereotactic body radiation therapy for spine metastases

Kim¹, H; Pyo, H; Park, HC; Lim, DH; Yu, JI; Park, W; Ahn, YC; Choi, DH; Oh, D; Noh, JM; Cho, WK; Yoo, GS; Jung, SH; Kim, ES; Lee, SH; Park, SJ; Lee, CS

Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer: A comparative analysis of proton versus photon therapy

Kim¹, N; Noh, JM; Lee, W; Park, B; Park, H; Park, JY; Pyo, H

Treatment modality and outcomes among early-stage non-small cell lung cancer patients with COPD a cohort study

Kang¹, N; Shin, SH; Noh, JM; Kang, D; Kim, H; Kwon, OJ; Pyo, H; Ahn, YC; Kim, HK; Choi, YS; Kim, J; Zo, JI; Shim, YM; Cho, J; Park, HY

Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancer

Jung¹, HA; Noh, JM; Sun, JM; Lee, SH; Ahn, JS; Ahn, MJ; Pyo, H; Ahn, YC; Park, K

Adjuvant therapy in stage IIIA-N2 non-small cell lung cancer after neoadjuvant concurrent chemoradiotherapy followed by surgery

Shin¹, S; Kim, HK; Cho, JH; Choi, YS; Kim, K; Kim, J; Zo, JI; Sun, JM; Ahn, MJ; Park, K; Pyo, H; Ahn, YC; Shim, YM

Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Yoon¹, HG; Oh, D; Ahn, YC; Noh, JM; Pyo, H; Cho, WK; Song, YM; Park, M; Hwang, NY; Sun, JM; Kim, HK; Zo, JI; Shim, YM

Impact Of Underlying Pulmonary Diseases On Treatment Outcomes In Early-Stage Non-Small Cell Lung Cancer Treated With Definitive Radiotherapy

Kim¹, H; Yoo, H; Pyo, H; Ahn, YC; Noh, JM; Ju, SG; Lee, W; Park, B; Kim, JM; Kang, N; Shin, SH; Chung, MP; Shin, S; Kim, HS; Park, M; Park, HY

Role of prophylactic cranial irradiation for elderly patients with limited-disease small-cell lung cancer: inverse probability of treatment weighting using propensity score

Kim¹, TG; Pyo, H; Ahn, YC; Noh, JM; Oh, D

Salvage Concurrent Chemo-radiation Therapy for Loco-regional Recurrence Following Curative Surgery of Non-small Cell Lung Cancer

Lee¹, KH; Ahn, YC; Pyo, H; Noh, JM; Park, SG; Kim, TG; Lee, E; Nam, H; Lee, H; Sun, JM; Ahn, JS; Ahn, MJ; Park, K

EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy

Park¹, SE; Noh, JM; Kim, YJ; Lee, HS; Cho, JH; Lim, SW; Ahn, YC; Pyo, H; Choi, YL; Han, J; Sun, JM; Lee, SH; Ahn, JS; Park, K; Ahn, MJ

Concurrent chemo-radiotherapy for unresectable non-small cell lung cancer invading adjacent great vessels on radiologic findings: is it safe?

Yoo¹, GS; Oh, D; Pyo, H; Ahn, YC; Noh, JM; Park, HC; Lim, DH

Preliminary result of definitive radiotherapy in patients with non-small cell lung cancer who have underlying idiopathic pulmonary fibrosis: comparison between X-ray and proton therapy

Kim¹, H; Pyo, H; Noh, JM; Lee, W; Park, B; Park, HY; Yoo, H

Investigations of line scanning proton therapy with dynamic multi-leaf collimator

Kim¹, DH; Park, S; Jo, K; Cho, S; Shin, E; Lim, DH; Pyo, H; Han, Y; Suh, TS

The more and the heavier may not always be an answer

Pyo¹, H; Lee, SH; Kim, J

Recurrence dynamics after trimodality therapy (Neoadjuvant concurrent chemoradiotherapy and surgery) in patients with stage IIIA (N2) lung cancer

Lee¹, J; Kim, HK; Park, BJ; Cho, JH; Choi, YS; Zo, JI; Shim, YM; Pyo, H; Ahn, YC; Ahn, JS; Ahn, MJ; Park, K; Kim, J

Randomized Phase II Trial Comparing Chemoradiotherapy with Chemotherapy for Completely Resected Unsuspected N2-Positive Non-Small Cell Lung Cancer

Sun¹, JM; Noh, JM; Oh, D; Kim, HK; Lee, SH; Choi, YS; Pyo, H; Ahn, JS; Jung, SH; Ahn, YC; Kim, J; Ahn, MJ; Zo, JI; Shim, YM; Park, K

Normal lung sparing Tomotherapy technique in stage III lung cancer

Hong¹, CS; Ju, SG; Ahn, YC; Yoo, GS; Noh, JM; Oh, D; Chung, K; Pyo, H; Jo, K

Role of Adjuvant Thoracic Radiation Therapy and Full Dose Chemotherapy in pN2 Non-small Cell Lung Cancer: Elucidation Based on Single Institute Experience

Park¹, H; Oh, D; Ahn, YC; Pyo, H; Noh, JM; Sun, JM; Ahn, JS; Ahn, MJ; Park, K; Kim, HK; Choi, YS; Kim, J; Zo, JI; Shim, YM

Development of patient-specific phantoms for verification of stereotactic body radiation therapy planning in patients with metallic screw fixation

Oh D1¹, Hong CS1, Ju SG1, Kim M1, Koo BY1, Choi S1, Park HC1, Choi DH1, Pyo H1.

Do New pN Subclassifications Proposed by IASLC's Lung Cancer Staging Project Agree with ypN Categories after Trimodality Therapy for Initial N2 Disease?

Kim H1¹, Ahn YC2, Pyo H1, Oh D1, Noh JM1, Sun JM3, Ahn JS3, Ahn MJ3, Park K3, Choi YS4, Kim J4, Zo JI4, Shim YM4, Lee M5, Han J5.

Radiation Therapy Alone in cT1-3N0 Non-small Cell Lung Cancer Patients Who Are Unfit for Surgical Resection or Stereotactic Radiation Therapy: Comparison of Risk-Adaptive Dose Schedules

Cho WK1¹, Noh JM1, Ahn YC1, Oh D1, Pyo H1.

Ablative dose proton beam therapy for stage I and recurrent non-small cell lung carcinomas

Lee SU1¹, Moon SH2,3,4, Cho KH1, Pyo HR5, Kim JY1, Kim DY1, Kim TH1, Suh YG1, Kim YJ1.

Effect of Radiation Therapy Techniques on Outcome in N3-positive IIIB Non-small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy

Noh JM1¹, Kim JM1, Ahn YC1, Pyo H1, Kim B1, Oh D1, Ju SG1, Kim JS1, Shin JS1, Hong CS1, Park H1, Lee E1.

Definitive Bimodality Concurrent Chemoradiotherapy in Patients with Inoperable N2-positive Stage IIIA Non-small Cell Lung Cancer

Noh JM1¹, Ahn YC1, Lee H2, Pyo H1, Kim B1, Oh D1, Park H1, Lee E1, Park K3, Ahn JS3, Ahn MJ3, Sun JM3.

Radical prostatectomy versus external beam radiotherapy for localized prostate cancer Comparison of treatment outcomes

Significance of early prostate-specific antigen values after salvage radiotherapy in recurrent prostate cancer patients treated with surgery

Chang JH1¹, Park W, Park JS, Pyo H, Huh SJ, Choi HY, Lee HM, Jeon SS, Seo SI.

Pretreatment Clinical Mediastinal Nodal Bulk and Extent do not Influence Survival in N2-Positive Stage IIIA Non-small Cell Lung Cancer Patients Treated with Trimodality Therapy

Lee H1¹, Ahn YC, Pyo H, Kim B, Oh D, Nam H, Lee E, Sun JM, Ahn JS, Ahn MJ, Park K, Choi YS, Kim J, Zo JI, Shim YM.

Suggestion for the prostatic fossa clinical target volume in adjuvant or salvage radiotherapy after a radical prostatectomy

Park JS1¹, Park W2, Pyo HR1, Park BK3, Park SY3, Choi HY4, Lee HM4, Jeon SS4, Seo SI4, Jeong BC4, Jeon HG4.

Involvement of inducible nitric oxide synthase in radiation-induced vascular endothelial damage

Hong CW1¹, Kim YM, Pyo H, Lee JH, Kim S, Lee S, Noh JM.

A phase II study of hypofractionated proton therapy for prostate cancer

Kim YJ1¹,?Cho KH,?Pyo HR,?Lee KH,?Moon SH,?Kim TH,?Shin KH,?Kim JY,?Lee SB,?Nam BH.

Different Cell Cycle Modulation by Celecoxib at Different Concentrations

Kim YM1¹, Pyo H.

Superiority of conventional intensity-modulated radiotherapy over helical tomotherapy in locally advanced non-small cell lung cancer A comparative plan analysis

Song C1¹, Pyo H, Kim J, Lim YK, Kim WC, Kim HJ, Kim DW, Cho KH.

Celecoxib Enhances the Radiosensitizing Effect of 7-Hydroxystaurosporine (UCN-01) in Human Lung Cancer Cell Lines

Kim YM1¹, Jeong IH, Pyo H.

Cooperative Enhancement of Radiosensitivity After Combined Treatment of 17-(Allylamino)-17-Demethoxygeldanamycin and Celecoxib in Human Lung and Colon Cancer Cell Lines

Kim YM1¹, Pyo H.

Systematic Analyses of Genes Associated with Radiosensitizing Effect by Celecoxib, a Specific Cyclooxygenase-2 Inhibitor

Kim YM1¹, Shin YK, Jun HJ, Rha SY, Pyo H.

PROTON RANGE UNCERTAINTY DUE TO BONE CEMENT INJECTED INTO THE VERTEBRA IN RADIATION THERAPY PLANNING

Lim YK1¹, Hwang UJ, Shin D, Kim DW, Kwak J, Yoon M, Lee DH, Lee SB, Lee SY, Park SY, Pyo HR.

Ataxia Telangiectasia and Rad3-Related Overexpressing Cancer Cells Induce Prolonged G(2) Arrest and Develop Resistance to Ionizing Radiation

Kim YM1¹, Lee YM, Park SY, Pyo H.

TREATMENT-RELATED PNEUMONITIS AND ACUTE ESOPHAGITIS IN NON-SMALL-CELL LUNG CANCER PATIENTS TREATED WITH CHEMOTHERAPY AND HELICAL TOMOTHERAPY: IN REGARD TO SONG ET AL. REPLY

Song CH1¹, Pyo H, Moon SH, Kim TH, Kim DW, Cho KH.

Gefitinib radiosensitizes non-small cell lung cancer cells through inhibition of ataxia telangiectasia mutated

Park SY1¹, Kim YM, Pyo H.